Skip to main content

Pfizer, BioNTech ask FDA for full approval of COVID-19 vaccine

Pfizer and BioNTech announced Friday that they have asked federal regulators for full approval of its COVID-19 vaccine, authorization that would allow them to market the shot directly to Americans.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.